Glucose oxidase (GOX) has emerged as a powerful therapeutic agent that exploits this metabolic vulnerability through targeted glucose depletion.
First-pass extracted concept
glucose oxidase
Candidate: concept label1 source documents3 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
GOX
Evidence Snippets
Supporting Sources
Linked Claims
GOX-mediated modulation of tumor microenvironment acidity, hydrogen peroxide concentration, and oxygen tension creates favorable conditions for combination therapies and enhances efficacy of multiple treatment modalities.
Nanocarrier technology addresses critical limitations of native GOX including systemic toxicity, short circulation half-life, immunogenicity, and instability in physiological environments.
Glucose oxidase exploits tumor metabolic vulnerability through targeted glucose depletion.